TVTX Travere Therapeutics, Inc. logo

TVTX Travere Therapeutics, Inc.

Healthcare
$44.43-0.69%ClosedMarket Cap: $4.13B

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

299

13F Shares

102,194,543

Ownership %

114.5%

New Positions

76

Increased Positions

169

Closed Positions

37

Reduced Positions

97

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
PJPInvesco Pharmaceuticals ETF382,2892.73%
PTHInvesco Dorsey Wright Healthcare Momentum ETF77,8901.92%
SBIOALPS Medical Breakthroughs ETF75,0961.67%
HELXFranklin Genomic Advancements ETF10,1291.36%
BBPVirtus Biotech ETF24,2391.32%
XBI2,863,1921.14%
LABUDirexion Daily S&P Biotech Bull 3X ETF143,4200.80%
VMNFX74,9560.75%
SFLOVictoryShares Small Cap Free Cash Flow ETF78,5580.45%
VSTCX172,9900.28%
IBBiShares Biotechnology ETF674,6000.24%
VEXPX1,210,0150.22%
VEXRX1,210,0150.22%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF53,9550.18%
IWOiShares Russell 2000 Growth ETF631,7300.15%
NLO631,7300.15%
VTWG70,8730.15%
VSEQX374,8460.15%
BBSCJPMorgan BetaBuilders U.S. Small Cap Equity ETF32,8290.14%
VFMO37,0030.12%